Semble

Semble is a UK healthcare-management platform serving outpatient providers, raising £30m in a Series C on 4 June 2026 led by Revaia, with Octopus Ventures, Mercia and Partech participating. The company provides practice-management software for outpatient and specialist clinic operators, covering appointment scheduling, patient records, billing and workflow management across a fragmented provider market. The round includes plans for expansion across Europe, with France named as an early target.

Outpatient healthcare management is a historically underdeveloped segment for software investment, with many Independent specialist clinics and outpatient providers still running on legacy systems or paper-based workflows. Semble's platform targets this fragmentation by offering cloud-native practice-management tooling to the growing private and semi-private outpatient sector in the UK and Europe. The European expansion reflects a broader trend of UK healthtech companies using their NHS-adjacent credibility as a reference customer base to open European markets.

The Series C investor roster spans UK (Octopus Ventures, Mercia) and continental European (Revaia, Partech) VCs, which is operationally useful for a company planning cross-border expansion. Revaia, a growth-equity fund with a strong European healthcare portfolio, taking the lead at Series C gives Semble access to relationships with European health system operators and regulatory expertise across multiple jurisdictions.